1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Uveitis Global Clinical Trials Review, H1, 2016

Uveitis Global Clinical Trials Review, H1, 2016

  • January 2016
  • -
  • GlobalData
  • -
  • 162 pages

Uveitis Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “Uveitis Global Clinical Trials Review, H1, 2016" provides an overview of Uveitis clinical trials scenario. This report provides top line data relating to the clinical trials on Uveitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Uveitis Global Clinical Trials Review, H1, 2016
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Uveitis to Ophthalmology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Uveitis to Ophthalmology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Uveitis Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Uveitis 29
Jan 05, 2016: Clearside Biomedical Announces Positive Topline Data from Phase 2 Clinical Trial for the Treatment of Macular Edema Associated with Non-Infectious Uveitis 29
Dec 07, 2015: Clearside Biomedical, Inc. Enrolls First Patient in Phase 3 Clinical Trial of CLS-TA Using Suprachoroidal Drug Administration 29
Clinical Trial Profile Snapshots 30
Appendix 159
Abbreviations 159
Definitions 159
Research Methodology 160
Secondary Research 160
About GlobalData 161
Contact Us 161
Disclaimer 161
Source 162

List of Tables
Uveitis Therapeutics, Global, Clinical Trials by Region, 2016* 6
Uveitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Uveitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Uveitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Uveitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Uveitis Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Uveitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
Uveitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
Proportion of Uveitis to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 14
Uveitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Uveitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Uveitis to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 17
Uveitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Uveitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Uveitis Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Uveitis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Uveitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Uveitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Uveitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Uveitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Uveitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Uveitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Uveitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List of Figures
Uveitis Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Uveitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Uveitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Uveitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Uveitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Uveitis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Uveitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
Uveitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
Proportion of Uveitis to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 14
Uveitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Uveitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Uveitis to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 17
Uveitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Uveitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Uveitis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Uveitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Uveitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Uveitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Uveitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Uveitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Uveitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Uveitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Uveitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 160

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung ...

OpportunityAnalyzer: Myelofibrosis - Opportunity Analysis and Forecasts to 2025

OpportunityAnalyzer: Myelofibrosis - Opportunity Analysis and Forecasts to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

OpportunityAnalyzer: Myelofibrosis - Opportunity Analysis and Forecasts to 2025 Summary Myelofibrosis (MF) is a rare blood disorder, which is characterized by bone marrow fibrosis. Currently, there is ...

OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecast to 2025

OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecast to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecast to 2025 Summary Endometriosis is an estrogen-dependent, chronic, inflammatory disease characterized by the appearance and growth of ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.